Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release
Crossref DOI link: https://doi.org/10.1007/s40261-014-0204-3
Published Online: 2014-06-07
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Imanaka, Keiichiro
Tominaga, Yushin
Etropolski, Mila
Ohashi, Hiroki
Hirose, Keiichiro
Matsumura, Taka
License valid from 2014-06-07